Jefferies Group’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-83,000
Closed -$2.83M 1822
2021
Q4
$2.83M Buy
+83,000
New +$3.25M 0.02% 666
2019
Q3
Sell
-9,129
Closed -$200K 2920
2019
Q2
$200K Buy
9,129
+4,170
+84% +$91.5K ﹤0.01% 2135
2019
Q1
$101K Buy
4,959
+3,453
+229% +$60K ﹤0.01% 2113
2018
Q4
$19K Buy
+1,506
New +$22.4K ﹤0.01% 2085
2017
Q4
Sell
-11,385
Closed -$127K 2695
2017
Q3
$127K Buy
+11,385
New +$111K ﹤0.01% 2143

Other funds holding NEO

Jefferies Group's NEO Position: Q1 2022 in Review

Jefferies Group sold out of NeoGenomics (NEO) in Q1 2022, closing a stake of 83,000 shares — an estimated $2.83M sold.

Jefferies Group first reported a position in NEO in Q3 2017 and held it in 5 quarters. The position peaked at $2.83M in Q4 2021. 279 funds tracked by Wall St. Rank hold NEO as of Q1 2022.

  • Jefferies Group reported no remaining NeoGenomics position as of Q1 2022 after selling out during the quarter.
  • Jefferies Group sold 83,000 NeoGenomics shares in Q1 2022, an estimated $2.83M.
  • Jefferies Group first reported a position in NeoGenomics in Q3 2017 and held it in 5 quarters.
  • Jefferies Group's NeoGenomics position peaked at $2.83M in Q4 2021.
  • 279 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2022.

Based on Jefferies Group's 13F filing for Q1 2022, filed 16 May 2022.